9% of multiple sclerosis patients taking dimethyl fumarate have a severe reduction in CD8+T lymphocytes (CD8+< 100 mm(3)) but have only grade 1 lymphopenia when measured as absolute lymphocyte count

9% of multiple sclerosis patients taking dimethyl fumarate have a severe reduction in CD8+T lymphocytes (CD8+< 100 mm(3)) but have only grade 1 lymphopenia when measured as absolute lymphocyte count Article

Web of Science: 000383267201442

Cited authors

Spinelli, C.; Bagert, B.

Authors

Bagert, Bridget, MD, MPH

Publication date

2016

Published in

Multiple Sclerosis Journal Journal

International Standard Serial Number (ISSN)

1352-4585

Start page

341

End page

342

Volume

22